Congenital adrenal hypoplasia caused by 21-hydroxylase deficiency in patients undergoing an assisted reproductive technology programs


Cite item

Full Text

Abstract

One hundred and eight patients included into the assisted reproductive technology (ART) program were examined. Heterozygous carriage of CYP21B gene mutation was revealed in 41 (38%) patients (26 females and 15 males). CYP21B gene deletion and duplication were 70.7 and 24.4%, respectively. HLA Class I antigens was shown to play an important role in the diagnosis of heterozygous carriage of this disease. When the markers of HLA B 14 and B 35 were available, CYP21B gene mutation was found in 68% of cases. Six cases had CYP21B gene mutation in a married couple. Awareness of the heterozygous carriage of the mutant CYP21B gene will assist one to make a necessary correction of treatment, thus enhancing the efficiency of an in vitro fertilization program and promoting the birth of healthy baby without adrenal hypoplasia within the framework of the ART program.

About the authors

Zh I Glinkina

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

Email: janna435@yandex.ru
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

L N Kuzmichev

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

V A Bakharev

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

I G Dzenis

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

G D Azizova

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

V G Mikayelyan

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Russian Agency for Medical Technologies

M V Ikonnikov

OOO Abbott Laboratories, Moscow

молекулярно-диагностическое подразделение; ООО Абботт Лэбораториз, Москва; OOO Abbott Laboratories, Moscow

References

  1. Дзенис И. Г. Современные пути диагностики и профилактики наследственной недостаточности 21-гидроксилазы: Дис. ... д-ра мед. наук. - М., 1994.
  2. Дуринян Э. Р. Клинико-патогенетическое обоснование дифференцированного подхода к лечению пациенток с синдромом поликистозных яичников: Дис. ... канд. мед. наук. - М., 1997.
  3. Осиновская Н. С. // Молекулярно-биологические технологии в медицинской практике. - Новосибирск, 2006. - Вып. 9. - С. 84-108.
  4. Раисова А. Т. Невынашивание беременности у женщин репродуктивного возраста: Дис. ... д-ра мед. наук. - М., 1990.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies